Market Features

Prison Officials Deny Madoff Cancer Reports

 

The U.S. Bureau of Prisons has denied various media reports that convicted fraudster Bernie Madoff has cancer.

The notion that Madoff had been diagnosed with the disease first emerged in an item published by the New York Post Monday.

The agency's chief spokesperson, Traci Billingsley, said in a statement, "While the NY Post story is full of inaccuracies, and we can't specifically address all of them, we can tell you that Bernie Madoff is not terminally ill, and has not been diagnosed with cancer."

The Post item -- later seconded by The Wall Street Journal, which cited "sources familiar with the situation" -- maintained that Madoff had been taking numerous pills for an unnamed type of cancer. The Post based its story on a fellow inmate at a federal prison in Burner, N.C., who said that Madoff spoke about his cancer "all the time."

The Journal, meanwhile, has since stepped back a bit from its earlier claim that it had "confirmed" the Post report, but said in an update online that its source continues to maintain that Madoff has a "serious" type of cancer.

Madoff, 71, arrived at the North Carolina prison complex in June to serve a 150-year sentence for masterminding the largest Ponzi scheme on record.

Lawyers for Madoff and his wife, Ruth, have so far been silent on the matter, according to the Post.

The Madoff Mess
For more from TheStreet on the Madoff scandal, see:
  • AIG + Bernie Madoff = Litigation
  • Madoff Begins Sentence He Can Never Finish
  • Trustee Squeezes $235M From Madoff Feeder
  • Protect Yourself in Post-Madoff Investing World
  • >To order reprints of this article, click here: Reprints

    This article was written by a staff member of TheStreet.com.

    TheStreet Premium Services

    Jim Cramer
    Jim Cramer's Action Alerts PLUS:
    Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
    OptionsProfits
    OptionsProfits:
    Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
    Real Money
    Real Money:
    Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
    Stocks Under $10
    Stocks Under $10:
    Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
    To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
    blog comments powered by Disqus
    Dow Jones S&P 500 NASDAQ 10-Year Note
    12,393.45 1,310.33 2,827.34 15.81
    Oil *
    101.78
    DOWN
    26.41
    DOWN
    2.99
    DOWN
    10.02
    DOWN
    0.44
    10 Yr
    1.58%
    SPDR Gold
    151.62
    -0.21%
    -0.23%
    -0.35%
    -2.71%
    Data delayed 20 minutes

    Top Stories and Tools

    Articles From

    After the Bell

    Before the Bell

    Booyah! Newsletter

    Midday Bell

    TheStreet Top 10 Stories

    Winners & Losers

    We respect your privacy.
    Podcasts

    Connect with TheStreet